gamma-coniceine: isolated from seeds of Conium maculatum (poison hemlock); structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Conium | genus | A plant genus of the family APIACEAE that is a source of coniine.[MeSH] | Apiaceae | A large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH] |
| Conium maculatum | species | Conium maculatum is a large toxic umbelliferous plant, which contains the alkaloid coniine which affects the nervous system. The dried, fully grown, unripe fruit has sedative, anodyne, and antispasmodic effects.[MeSH] | Apiaceae | A large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 442632 |
| CHEBI ID | 10561 |
| SCHEMBL ID | 1760704 |
| MeSH ID | M0133442 |
| Synonym |
|---|
| 2-propyl-3,4,5,6-tetrahydro-pyridine |
| pyridine, 2,3,4,5-tetrahydro-6-propyl- |
| brn 0106092 |
| gamma-conicein |
| 2,3,4,5-tetrahydro-6-propylpyridine |
| gamma-coniceine |
| 1604-01-9 |
| 6-propyl-2,3,4,5-tetrahydropyridine |
| AKOS006277083 |
| unii-phk73qlk4z |
| phk73qlk4z , |
| 5-20-04-00345 (beilstein handbook reference) |
| 2-n-propyl-3,4,5,6-tetrahydropyridine |
| .gamma.-coniceine |
| 2-n-propyl-.delta.-piperidine |
| coniceine, gamma- |
| .gamma.-coniceine [mi] |
| SCHEMBL1760704 |
| CHEBI:10561 |
| PQSOVRNZJIENNW-UHFFFAOYSA-N |
| 6-propyl-2,3,4,5-tetrahydropyridine # |
| .gamma.-conicein |
| 2-propyl-3,4,5,6-tetrahydropyridine |
| DTXSID00166872 |
| 6-propyl-2,3,4,5-tetrahydro-pyridine |
| Q27108656 |
| BAA60401 |
| EN300-219505 |
| Class | Description |
|---|---|
| tetrahydropyridine | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.15) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 2 (33.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||